These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Girdin maintains the stemness of glioblastoma stem cells. Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337 [TBL] [Abstract][Full Text] [Related]
25. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
26. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433 [TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473 [TBL] [Abstract][Full Text] [Related]
28. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687 [TBL] [Abstract][Full Text] [Related]
30. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311 [TBL] [Abstract][Full Text] [Related]
31. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway. Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897 [TBL] [Abstract][Full Text] [Related]
32. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma. Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971 [TBL] [Abstract][Full Text] [Related]
33. Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Betschinger J; Mechtler K; Knoblich JA Cell; 2006 Mar; 124(6):1241-53. PubMed ID: 16564014 [TBL] [Abstract][Full Text] [Related]
34. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1. Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824 [TBL] [Abstract][Full Text] [Related]
35. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484 [No Abstract] [Full Text] [Related]
36. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964 [TBL] [Abstract][Full Text] [Related]
38. Role of Wnt5a in the proliferation of human glioblastoma cells. Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179 [TBL] [Abstract][Full Text] [Related]
39. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Sherry MM; Reeves A; Wu JK; Cochran BH Stem Cells; 2009 Oct; 27(10):2383-92. PubMed ID: 19658181 [TBL] [Abstract][Full Text] [Related]
40. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]